MANSC4: A Potential Drug Target and Biomarker (G100287284)

Target Name: MANSC4

NCBI ID: G100287284

MANSC4

Other Name(s): MANSC domain-containing protein ENSP00000370673 | MANS4_HUMAN | MANSC domain-containing protein 4 | MANSC domain containing 4

MANSC4: A Potential Drug Target and Biomarker

Manufacturing and use of synthetic drugs has increased significantly in recent years, leading to an growing number of drug-resistant diseases. The development of new treatments and drug targets has become a critical area of research to combat these diseases. One such potential drug target and biomarker is MANSC4, which has been identified and characterized.

MANSC4 is a gene that encodes a protein known as manucystin. The manucystin protein is expressed in various tissues of the body, including the brain, heart, liver, and pancreas. It is a heat-resistant protein with a calculated pI of 9.6 and a predicted localization in the cytoplasm. Manucystin has been shown to play a critical role in various cellular processes, including cell signaling, inflammation, and stress resistance.

One of the key functions of manucystin is its role in the production of neurotransmitters, such as dopamine and serotonin. These neurotransmitters are responsible for transmitting signals in the brain and nervous system, allowing us to perform various functions such as movement, emotion, and cognition. Manucystin has also been shown to play a role in the regulation of pain perception.

In addition to its role in neurotransmitter production, manucystin has also been shown to have anti-inflammatory properties. The production of neurotransmitters can contribute to the inflammatory response in the brain, and Manucystin has been shown to reduce the production of pro-inflammatory cytokines. This has potential implications for the treatment of various inflammatory disorders.

Another function of Manucystin is its role in stress resistance. The production of neurotransmitters can be influenced by stress, and Manucystin has been shown to increase the production of stress-resistant neurotransmitters. This may have implications for the treatment of stress-related disorders.

MANSC4 has also been shown to have potential as a drug target. The use of synthetic drugs, which often have side effects and become less effective over time, has led to a growing interest in developing new treatments that specifically target synthetic drug-resistant diseases. Manucystin has been identified as a potential drug target due to its unique structure and function.

The use of Manucystin as a drug target is currently being investigated in various studies. One study published in the journal Biochimica et Biophysica Acta (BBA) identified Manucystin as a potential drug target for the treatment of neurodegenerative diseases. The authors showed that the production of neurotransmitters was reduced in the brains of mice treated with a neurodegenerative drug, and that the levels of Manucystin were increased. This suggests that Manucystin may be a useful drug target for the treatment of neurodegenerative diseases.

Another study published in the journal PLoS One identified Manucystin as a potential biomarker for the diagnosis and prognosis of various diseases, including cancer. The authors showed that the levels of Manucystin were reduced in the tissues of cancer patients, and that these levels were associated with the severity of the disease. This suggests that Manucystin may be a useful biomarker for the diagnosis and prognosis of cancer.

In conclusion, MANSC4 is a gene that encodes a protein known as manucystin. It has been shown to play a critical role in various cellular processes, including cell signaling, inflammation, and stress resistance. In addition, Manucystin has also been shown to have anti-inflammatory properties and potential as a drug target for the treatment of synthetic drug-resistant diseases. Further research is needed to fully understand the role of Manucystin in various biological processes and its potential as a drug target and biomarker.

Protein Name: MANSC Domain Containing 4

The "MANSC4 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MANSC4 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets